NR1H4 and Obesity: In addition, in a diet-induced obesity mouse model, the FXR/TGR5 dual agonist suppresses diet-induced kidney disease by changing the composition of kidney bile acids, reducing their accumulation, and decreasing triglyceride and ceramide levels in the kidney.